Post-Doctoral Associate, Neuro-Oncology
University of Miami

Current Employees:

If you are a current Staff, Faculty or Temporary employee at the University of Miami, please click here to log in to Workday to use the internal application process. To learn how to apply for a faculty or staff position using the Career worklet, please review this tip sheet.

The University of Miami/UHealth Department of SCCC has an exciting opportunity for a Full Time, Postdoc Associate - Neuro-Oncology to work at our UHealth Medical campus. The Iavarone Lab is seeking an outstanding candidate for a Postdoctoral Research position to join the system biology and bioinformatics team. The Iavarone Lab studies brain tumors and his group develops and applies computational and systems biology approaches to dissect the molecular mechanisms that drive brain tumorigenesis, the composition tumor microenvironment in distinct subtypes of tumors and therapy resistance. The candidate will analyze and integrate high-throughput multiomics data including transcriptomic, genomic, epigenomic, functional genomic, chemical genomic and proteomic data from bulk tumors and single-cells to model context-specific cellular/molecular networks and identify actionable targets, biomarkers that could be utilized for the development of precision medicine in patients with brain tumors.

CORE JOB FUNCTIONS
1. Conducts research on specific areas of study as assigned.
2. Prepares research reports and technical papers for publishing.
3. Investigates the feasibility of applying a wide variety of scientific principles and theories.
4. Maintains substantial knowledge of state-of-the-art principles and theories.
5. Develops advanced analytical models and systems and provides solutions and analyses to support
strategic and tactical decisions.
6. Adheres to University and unit-level policies and procedures and safeguards University assets

Department Specifics:

The Iavarone Lab provides a highly interactive environment with projects involving basic and clinical research collaborators, access to high performance computing clusters, cloud computing environment, innovative visualization tools, highly automated analytical pipelines and teamwork with scientists who have deep experience in data analysis, data management and delivery of high-quality results for highly competitive projects. Innovative research will be supported by the lab's infrastructure, including a state-of-the-art wet lab for experimental validation. As a member of the lab the candidate will interact with leaders in cancer and translational research within and outside the institution and at national/international meetings.

Candidates with expertise in oncology, mining algorithms, big data mining, machine learning, bioinformatics and design, analysis, implementation, and experimental evaluation are encouraged to apply.

Experience with omics data analysis using R or Python and familiarity with linux/unix is required. Experience and knowledge in chemical biology, network biology, parallel computing, web development and visualization is also highly desirable. Candidates are expected to exercise independent discretion and judgment in carrying out research activities and develop methods of research.

Requirements:
Education: MD or Ph.D. in relevant field required. PhD in Computational Biology, Bioinformatics, or a related field preferred.

Experience: No prior experience required. First Author Scientific Publications preferred.

Knowledge, Skills, and Attitudes:

•Skill in collecting, organizing, and analyzing data.

•Ability to recognize, analyze, and solve a variety of problems.

•Ability to exercise sound judgment in making critical decisions.

Work from the labs includes:

Garofano L et al. Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities. Nature Cancer Feb;2(2):141-156; doi: 10.1038/s43018-020-00159-4, 2021. [see also Hubert, C.G. and Lathia J.D. Seeing the GBM diversity spectrum. Nature Cancer, Feb;2(2):135, 2021].

Lee SB et al. Proline Hydroxylation Primes protein kinases for autophosphorylation and activation. Mol. Cell 79:376-389, 2020.

*D'Angelo F. et al. The molecular landscape of glioma in patients with Neurofibromatosis 1. Nature Medicine, 25:176-187, 2019

Frattini Vet al. A metabolic function of FGFR3-TACC3 gene fusions in cancer. Nature, 553: 222-227, 2018. Nature, 553: 222-227, 2018; [see also RESEARCH WATCH "FGFR3-TACC3 Activates Mitochondrial Respiration via PIN4 Phosphorylation" Cancer Discovery Published Online First January 12, 2018 doi: 10.1158/2159-8290.CD-RW2018-008; RESEARCH HIGHLIGHTS "Fusion Power" Nature Reviews Cancer Published online January 25, 2018 doi:10.1038/nrc.2018.2; NATURE.COM/PATHOLOGY "Gene fusions in cancer metabolism" Laboratory Investigation 98:271, 2018].

Lee SB et al. An ID2-dependent-mechanism for VHL inactivation in cancer. Nature (Article), 529:172-177, 2016; [see also RESEARCH WATCH "Hypoxia promotes cancer stem cells via ID2-dependent VHL inactivation" Cancer Discovery (6: 120, 2016). RESEARCH HIGHLIGHTS "Pathway to stemness" Nature Reviews Cancer (16: 70, 2016)]

Interested candidates please apply online and in addition you may also send your CV to axi435@miami.edu

The University of Miami offers competitive salaries and a comprehensive benefits package including medical, dental, tuition remission and more.

UHealth-University of Miami Health System, South Florida's only university-based health system, provides leading-edge patient care powered by the ground breaking research and medical education at the Miller School of Medicine. As an academic medical center, we are proud to serve South Florida, Latin America and the Caribbean. Our physicians represent more than 100 specialties and sub-specialties, and have more than one million patient encounters each year. Our tradition of excellence has earned worldwide recognition for outstanding teaching, research and patient care. We're the challenge you've been looking for.

Patient safety is a top priority. As a result, during the Influenza ("the flu") season (September through April), the University Of Miami Miller School Of Medicine requires all employees who provide ongoing services to patients, work in a location (all Hospitals and clinics) where patient care is provided, or work in patient care or clinical care areas, to have an annual influenza vaccination. Failure to meet this requirement will result in rescinding or termination of employment.

The University of Miami is an Equal Opportunity Employer - Females/Minorities/Protected Veterans/Individuals with Disabilities are encouraged to apply. Applicants and employees are protected from discrimination based on certain categories protected by Federal law. Click here for additional information.

Job Status:
Full time

Employee Type:
Staff

Pay Grade:
A9